Last edition
News about
Novartis and a consortium of life sciences companies announced an important collaboration to accelerate the development, manufacture and delivery of vaccines, diagnostics, and treatments for COVID-19 in response to the pandemic. The industry brings a range of assets, resources, and expertise needed to identify effective and scalable solutions
To help fight the current COVID-19 pandemic in India, specialty chemicals company LANXESS India has donated its highly effective Rely+On™ Virkon™ disinfectant to Thane Municipal Corporation (TMC) to reduce the cross contamination of COVID-19 in civic hospitals and other establishments
Mylab Ships First Batch of COVID 19 Test Kits To Government And Private Labs
First batch of Made in India Testing kit for Covid-19 to be shipped today, Government and private labs approved by ICMR to conduct tests. Mylab can ramp-up capacity from 20,000 to 50,000 kits a day if needed
BELLUS Health Inc.is pleased to announce that it has closed the transaction announced on March 23, 2020 in accordance with the asset purchase and sale agreement entered into with adMare BioInnovations’ NEOMED Institute
Pfizer announced that the US Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for Eucrisa (crisaborole) ointment, 2%, extending the lower age limit from 24 months down to 3 months in children with mild-to-moderate atopic dermatitis (AD), also known as eczema
Genentech, a member of the Roche Group, announced the US Food & Drug Administration (FDA) has approved a randomized, double-blind, placebo-controlled phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA) to evaluate the safety and efficacy of intravenous Actemra (tocilizumab) plus standard
First Made in India COVID-19 tests kit by Mylab gets commercial approval from the government
Mylab is the first Indian company getting commercial COVID-19 PCR kit approved by CDSCO.Mylab COVID-19 test kits cost nearly one-fourth of the currently procured kits. Mylab uses advanced protocols which can reduces testing time by 65%
Insulin Gains New Pathway to Increased Competition: USA FDA
Today is a historic day and a landmark moment for patients with diabetes and other serious medical conditions, as insulin and certain other biologic drugs transition to a different regulatory pathway. This regulatory transition, mandated by Congress and implemented by the FDA, is incredibly important for patients
Philips increases production of critical health technology products to diagnose and treat COVID-19
Royal Philips, a global leader in health technology, announced that it is increasing the production of certain critical care products and solutions to help diagnose and treat patients with the new coronavirus disease (COVID-19).
DST invites proposals for prevention and therapy of COVID-19
The Technology Development Board (TDB), a statutory body under Department of Science and Technology (DST) has invited proposal applications from Indian companies to address protection and home-based therapeutic respiratory intervention for coronavirus (COVID-19) patients.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy